nach oben

Erschienen in:

01.10.2014

Factors Associated with Systemic Hypertension in Asthma

verfasst von: Susan Ferguson, Mihai C. Teodorescu, Ronald E. Gangnon, Andrea G. Peterson, Flavia B. Consens, Ronald D. Chervin, Mihaela Teodorescu

Erschienen in: Lung | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Asthmatics have unique characteristics that may influence cardiovascular morbidity. We tested the association of lower airway caliber, obstructive sleep apnea (OSA), and other asthma-related factors, with systemic hypertension (HTN).

Methods

Asthma individuals at specialty clinics completed the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ). Medical records were reviewed for diagnosed HTN, OSA and comorbidities, spirometry, and current medications. FEV₁% predicted was categorized as ≥80 (reference), 70–79, 60–69, and <60. SA-SDQ ≥36 for men and ≥32 for women defined high OSA risk.

Results

Among 812 asthmatics (mean age ± standard deviation: 46 ± 14 years), HTN was diagnosed in 191 (24 %), OSA in 65 (8 %), and OSA or high OSA risk (combined OSA variable) in 239 (29 %). HTN was more prevalent in lower FEV₁% categories (p < 0.0001), in subjects with OSA, and those with combined OSA variable (55 vs. 21 % and 46 vs. 14 %, respectively, both p < 0.0001). With adjustment for covariates, associations with HTN remained significant for some FEV₁% categories (70–79 % odds ratio = 1.60 [95 % CI 0.90–2.87]; 60–69 % 2.73 [1.28–5.79]; <60 % 0.96 [0.43–2.14]), and for OSA (2.20 [1.16–4.19]). The combined OSA variable in comparison with OSA alone demonstrated a stronger association with HTN (3.17 [1.99–5.04]) in a reiteration of this model. Inhaled corticosteroids (ICS) at lowest doses, in comparison to no ICS use had an independent “protective” association with HTN (0.44 [0.22–0.90]).

Conclusions

In this young population, worse lower airways obstruction and OSA were associated with HTN. In contrast, lower ICS doses attenuated likelihood for HTN. Adequate control of airway inflammation at appropriate ICS doses, and screening for OSA may reduce the burden of HTN in asthma.

American Thoracic Society, & Medical section of the American Lung Association (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136(1):225–244CrossRef

Auckley D, Moallem M, Shaman Z et al (2008) Findings of a Berlin Questionnaire survey: comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med 9:494–499CrossRefPubMed

Bettiol J, Bartsch P, Louis R et al (2000) Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels. Allergy 55:1134–1141CrossRefPubMed

Bjermer L (2007) Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. J Allergy Clin Immunol 120:1269–1275CrossRefPubMed

Capra V, Back M, Barbieri SS et al (2012) Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke. Med Res Rev. doi:10.1002/med.21251 PubMed

Center for Disease Control and Prevention: National Center for Health Statistics. US Department of Health and Human Services (2013) FastStats. Hypertension 2009–2010. http://www.cdc.gov/nchs/fastats/hyprtens.htm. Accessed 28 Apr 2013

Chae CU, Lee RT, Rifai N et al (2001) Blood pressure and inflammation in apparently healthy men. Hypertension 38:399–403CrossRefPubMed

Chan CS, Woolcock AJ, Sullivan CE (1988) Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 137:1502–1504CrossRefPubMed

Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2572CrossRefPubMed

10.

Ciftci TU, Ciftci B, Guven SF et al (2005) Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med 99:529–534CrossRefPubMed

11.

Denburg JA, Sehmi R, Saito H et al (2000) Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 106:S242–S246CrossRefPubMed

12.

Dogra S, Ardern CI, Baker J (2007) The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma 44:849–854CrossRefPubMed

13.

Douglass AB, Bornstein R, Nino-Murcia G et al (1994) The Sleep Disorders Questionnaire. I: creation and multivariate structure of SDQ. Sleep 17:160–167PubMed

14.

Girdhar A, Kumar V, Singh A et al (2011) Systemic inflammation and its response to treatment in patients with asthma. Respir Care 56:800–805CrossRefPubMed

15.

Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMed

16.

Guilleminault C, Quera-Salva MA, Powell N et al (1988) Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J 1:902–907PubMed

17.

Halasz A, Cserhati E, Kosa L et al (2003) Relationship between the tumor necrosis factor system and the serum interleukin-4, interleukin-5, interleukin-8, eosinophil cationic protein, and immunoglobulin E levels in the bronchial hyperreactivity of adults and their children. Allergy Asthma Proc 24:111–118PubMed

18.

Huiart L, Ernst P, Ranouil X et al (2005) Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 25:634–639CrossRefPubMed

19.

Jousilahti P, Salomaa V, Hakala K et al (2002) The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 89:381–385CrossRefPubMed

20.

Julien JY, Martin JG, Ernst P et al (2009) Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 124:371–376CrossRefPubMed

21.

Kapa S, Sert Kuniyoshi FH, Somers VK (2008) Sleep apnea and hypertension: interactions and implications for management. Hypertension 51:605–608CrossRefPubMed

22.

Libby P, Ridker PM, Hansson GK (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129–2138PubMedCentralCrossRefPubMed

23.

Lopez-Jimenez F, Sert Kuniyoshi FH, Gami A (2008) Obstructive sleep apnea: implications for cardiac and vascular disease. Chest 133:793–804CrossRefPubMed

24.

Martin RJ, Szefler SJ, Chinchilli VM et al (2002) Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 165:1377–1383CrossRefPubMed

25.

Nelson HS, Weiss ST, Bleecker ER et al (2006) The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129:15–26CrossRefPubMed

26.

Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829–1836CrossRefPubMed

27.

Pauletto P, Rattazzi M (2006) Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 21:850–853CrossRefPubMed

28.

Poch E (2003) Role of lipoxygenase metabolites in cardiovascular disease. Curr Hypertens Rep 5:1–2CrossRefPubMed

29.

Qureshi AI, Suri MF, Kirmani JF et al (2005) Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit 11:CR403–CR409PubMed

30.

Rasmussen F, Mikkelsen D, Hancox RJ et al (2009) High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J 33:382–388CrossRefPubMed

31.

Ryan S, Taylor CT, Mcnicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64:631–636PubMed

32.

Sin DD, Wu L, Man SF (2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127:1952–1959CrossRefPubMed

33.

Teodorescu M, Consens FB, Bria WF et al (2006) Correlates of daytime sleepiness in patients with asthma. Sleep Med 7:607–613CrossRefPubMed

34.

Teodorescu M, Peterson RG, Consens FB et al (2008) Predictors of systemic hypertension in patients with asthma. Am J Respir Crit Care Med 177:A90

35.

Thorleifsson SJ, Margretardottir OB, Gudmundsson G et al (2009) Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med 103:1548–1553PubMedCentralCrossRefPubMed

36.

US Department of Health and Human Services. National Institute of Health; National Heart, Lung and Blood Institute (2013) National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma. Full report 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed 15 Apr 2013

37.

Van Der Hooft CS, Heeringa J, Brusselle GG et al (2006) Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 166:1016–1020CrossRefPubMed

38.

Wei L, Macdonald TM, Walker BR (2004) Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764–770CrossRefPubMed

39.

Yokoyama A, Kohno N, Fujino S et al (1995) Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med 151:1354–1358CrossRefPubMed

40.

Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed

41.

Young T, Evans L, Finn L et al (1997) Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20:705–706PubMed

Titel: Factors Associated with Systemic Hypertension in Asthma
verfasst von: Susan Ferguson
Mihai C. Teodorescu
Ronald E. Gangnon
Andrea G. Peterson
Flavia B. Consens
Ronald D. Chervin
Mihaela Teodorescu
Publikationsdatum: 01.10.2014
Verlag: Springer US
Erschienen in: Lung / Ausgabe 5/2014
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-014-9600-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Factors Associated with Systemic Hypertension in Asthma